$ARMP
Armata Pharmaceuticals, Inc.

2014 Q4 Form 10-Q Financial Statement

#000114420414068950 Filed on November 14, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q4
Revenue $100.0K $0.00 -$250.0K
YoY Change -140.0% -100.0% -1350.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.560M $1.700M $1.250M
YoY Change 24.8% 39.34% 35.87%
% of Gross Profit
Research & Development $1.110M $1.804M $1.200M
YoY Change -7.5% 63.11% 114.29%
% of Gross Profit
Depreciation & Amortization $80.00K -$30.00K $10.00K
YoY Change 700.0% -250.0% -50.0%
% of Gross Profit
Operating Expenses $2.680M $4.946M $2.450M
YoY Change 9.39% 113.47% 65.54%
Operating Profit -$4.946M
YoY Change 113.19%
Interest Expense $1.930M $0.00 $3.110M
YoY Change -37.94% -100.0% -3555.56%
% of Operating Profit
Other Income/Expense, Net $0.00 -$24.33M $20.00K
YoY Change -100.0% -158.52% -84.62%
Pretax Income -$660.0K $21.21M $430.0K
YoY Change -253.49% -143.51% -129.66%
Income Tax
% Of Pretax Income
Net Earnings -$660.0K $19.39M $430.0K
YoY Change -253.49% -144.16% -129.66%
Net Earnings / Revenue -660.0%
Basic Earnings Per Share $0.10
Diluted Earnings Per Share -$22.00M $0.06 $21.50M
COMMON SHARES
Basic Shares Outstanding 187.2M shares 187.2M shares
Diluted Shares Outstanding 316.0M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.580M $9.790M $20.36M
YoY Change -67.68% 101.44% 2267.44%
Cash & Equivalents $6.581M $9.786M $20.36M
Short-Term Investments
Other Short-Term Assets $340.0K $450.0K $300.0K
YoY Change 13.33% 2.27% -61.04%
Inventory
Prepaid Expenses
Receivables $100.0K $27.00K $8.000K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.020M $10.09M $20.66M
YoY Change -66.02% 90.06% 1152.12%
LONG-TERM ASSETS
Property, Plant & Equipment $1.220M $1.175M $145.0K
YoY Change 741.38% 591.18% 3.57%
Goodwill $7.562M $4.329M $7.562M
YoY Change 0.0%
Intangibles $12.45M $12.45M $12.45M
YoY Change 0.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $21.60M $18.33M $20.55M
YoY Change 5.08% 5.15% 0.65%
TOTAL ASSETS
Total Short-Term Assets $7.020M $10.09M $20.66M
Total Long-Term Assets $21.60M $18.33M $20.55M
Total Assets $28.62M $28.42M $41.21M
YoY Change -30.56% 24.97% 86.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.170M $1.840M $2.150M
YoY Change -45.58% 24.32% 10.82%
Accrued Expenses $460.0K $450.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.868M $2.499M $2.391M
YoY Change -21.87% 68.85% -60.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $18.24M $20.29M $57.66M
YoY Change -68.37% -60.03%
Total Long-Term Liabilities $18.24M $14.58M $51.11M
YoY Change -64.31% -71.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.868M $2.499M $2.391M
Total Long-Term Liabilities $18.24M $14.58M $51.11M
Total Liabilities $23.19M $17.08M $63.13M
YoY Change -63.27% -67.3% 591.47%
SHAREHOLDERS EQUITY
Retained Earnings -$362.0M -$355.3M -$385.1M
YoY Change -6.0%
Common Stock $1.992M $1.872M $1.825M
YoY Change 9.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.437M $11.34M -$22.63M
YoY Change
Total Liabilities & Shareholders Equity $28.62M $28.42M $41.21M
YoY Change -30.56% 24.97% 86.74%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q4
OPERATING ACTIVITIES
Net Income -$660.0K $19.39M $430.0K
YoY Change -253.49% -144.16% -129.66%
Depreciation, Depletion And Amortization $80.00K -$30.00K $10.00K
YoY Change 700.0% -250.0% -50.0%
Cash From Operating Activities -$3.200M -$2.620M -$1.410M
YoY Change 126.95% 5.22% -5.37%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$140.0K $0.00
YoY Change 366.67% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$140.0K $0.00
YoY Change 366.67% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 16.92M
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -3.200M -2.620M -1.410M
Cash From Investing Activities 0.000 -140.0K 0.000
Cash From Financing Activities 0.000 0.000 16.92M
Net Change In Cash -3.200M -2.760M 15.51M
YoY Change -120.63% 9.52% -1134.0%
FREE CASH FLOW
Cash From Operating Activities -$3.200M -$2.620M -$1.410M
Capital Expenditures $0.00 -$140.0K $0.00
Free Cash Flow -$3.200M -$2.480M -$1.410M
YoY Change 126.95% 0.81% -4.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
11338000 USD
CY2014Q3 aphb Derivative Preferred Shares Conversion Liability
DerivativePreferredSharesConversionLiability
7633000 USD
CY2013Q4 aphb Derivative Preferred Shares Conversion Liability
DerivativePreferredSharesConversionLiability
34443000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
20534000 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1175000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
145000 USD
CY2014Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12446000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12446000 USD
CY2014Q3 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
377000 USD
CY2013Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
400000 USD
CY2014Q3 us-gaap Goodwill
Goodwill
4329000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
4329000 USD
CY2014Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
17152000 USD
CY2013Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
17175000 USD
CY2014Q3 us-gaap Assets
Assets
28419000 USD
CY2013Q4 us-gaap Assets
Assets
37854000 USD
CY2014Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1840000 USD
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2147000 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2499000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2147000 USD
CY2014Q3 us-gaap Other Additional Capital
OtherAdditionalCapital
1837000 USD
CY2013Q4 us-gaap Other Additional Capital
OtherAdditionalCapital
1837000 USD
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-178000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-65000 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-355312000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-378074000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
63155331 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
150283630 shares
us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
18400000 USD
CY2014Q3 aphb Reclassification From Derivative Liability To Equity
ReclassificationFromDerivativeLiabilityToEquity
741000 USD
us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
5900000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9786000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20355000 USD
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8000 USD
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
279000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
171000 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
10092000 USD
CY2014Q3 aphb Derivative Warrants Liability
DerivativeWarrantsLiability
6949000 USD
CY2013Q4 aphb Derivative Warrants Liability
DerivativeWarrantsLiability
16664000 USD
CY2014Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
14582000 USD
CY2013Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
51107000 USD
CY2014Q3 us-gaap Liabilities
Liabilities
17081000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
53254000 USD
CY2014Q3 us-gaap Preferred Stock Value
PreferredStockValue
87000 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
89000 USD
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
1872000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
1825000 USD
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
363032000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
358988000 USD
CY2013Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
-3000 USD
CY2014Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5378000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4687000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1106000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1804000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4777000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5377000 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1211000 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1632000 USD
us-gaap Operating Expenses
OperatingExpenses
10155000 USD
us-gaap Operating Expenses
OperatingExpenses
11574000 USD
CY2014Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
24334000 USD
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
2660000 USD
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
0 USD
CY2013Q3 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
23000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-15400000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28419000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37854000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1206000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1590000 USD
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
248000 USD
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1064000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0.22
CY2014Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
559358 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
559000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
473000 USD
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
8671040 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
8859978 shares
CY2014Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
8671040 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
8859978 shares
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
445000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
445000000 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
187159093 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
182535562 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
187159093 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
182535562 shares
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
333000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
310000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
2317000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
4946000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9822000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-11264000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2320000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4946000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-45617000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
34026000 USD
CY2013Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-41548000 USD
CY2014Q3 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
0 USD
us-gaap Interest Expense
InterestExpense
233000 USD
us-gaap Interest Expense
InterestExpense
0 USD
CY2013Q3 us-gaap Interest Expense
InterestExpense
9000 USD
CY2014Q3 us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Other Expenses
OtherExpenses
48510000 USD
us-gaap Other Expenses
OtherExpenses
-34026000 USD
CY2013Q3 us-gaap Other Expenses
OtherExpenses
41580000 USD
CY2014Q3 us-gaap Other Expenses
OtherExpenses
-24334000 USD
us-gaap Net Income Loss
NetIncomeLoss
-58332000 USD
us-gaap Net Income Loss
NetIncomeLoss
22762000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-43900000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
19388000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85688356 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
184445172 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99156809 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
187159093 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85688356 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
323604642 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99156809 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
315990084 shares
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-24000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-113000 USD
CY2013Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-21000 USD
CY2014Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-93000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-58356000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22649000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43921000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
19295000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
12943000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-57648000 USD
aphb Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
1758000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1437000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
759000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
2635000 USD
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3000000 USD
CY2013 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
50000 USD
CY2013 aphb Stock Issued During Period Value New Issues1
StockIssuedDuringPeriodValueNewIssues1
50000 USD
CY2013 aphb Stock Issued During Period Value Conversion Of Convertible Securities1
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities1
6615000 USD
aphb Stock Issued During Period Value Conversion Of Convertible Securities1
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities1
741000 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13000 USD
CY2013 aphb Stock Issued During Period Value Shares Released From Escrow
StockIssuedDuringPeriodValueSharesReleasedFromEscrow
0 USD
CY2013 aphb Stock Issued During Period Value New Issues2
StockIssuedDuringPeriodValueNewIssues2
15464000 USD
CY2013 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
0 USD
CY2013 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
41000 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-113000 USD
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
45617000 USD
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
-34026000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
3000000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2637000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
759000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Depreciation
Depreciation
66000 USD
us-gaap Depreciation
Depreciation
59000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1206000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
759000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
125000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
19000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-618000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-453000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-307000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
153000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
108000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
233000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4904000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9367000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
97000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1089000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-97000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1089000 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
7000000 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2000000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
26000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
8974000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
0 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
24000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-113000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3997000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-10569000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
862000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4859000 USD
aphb Compensation And Benefits
CompensationAndBenefits
679000 USD
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
659000 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
0 USD
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 USD
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
831000 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
AmpliPhi Biosciences Corp
dei Entity Central Index Key
EntityCentralIndexKey
0000921114
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
APHB
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
187159093 shares
us-gaap Severance Costs1
SeveranceCosts1
0 USD
us-gaap Severance Costs1
SeveranceCosts1
1510000 USD
CY2013Q3 us-gaap Severance Costs1
SeveranceCosts1
0 USD
CY2014Q3 us-gaap Severance Costs1
SeveranceCosts1
1510000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
659000 USD

Files In Submission

Name View Source Status
0001144204-14-068950-index-headers.html Edgar Link pending
0001144204-14-068950-index.html Edgar Link pending
0001144204-14-068950.txt Edgar Link pending
0001144204-14-068950-xbrl.zip Edgar Link pending
aphb-20140930.xml Edgar Link completed
aphb-20140930.xsd Edgar Link pending
aphb-20140930_cal.xml Edgar Link unprocessable
aphb-20140930_def.xml Edgar Link unprocessable
aphb-20140930_lab.xml Edgar Link unprocessable
aphb-20140930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v393056_10q.htm Edgar Link pending
v393056_ex10-1.htm Edgar Link pending
v393056_ex31-1.htm Edgar Link pending
v393056_ex31-2.htm Edgar Link pending
v393056_ex32-1.htm Edgar Link pending
v393056_ex32-2.htm Edgar Link pending